A Seamless, Phase 1/2, Multiple Ascending Dose, Proof of Concept Study of ATN-103 Administered to Subjects With Active Rheumatoid Arthritis on a Background of Methotrexate

Update Il y a 4 ans
Reference: EUCTR2008-007185-33

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the safety and clinical efficacy of multiple ascending doses (MAD) of ATN-103 administered SC to subjects with active RA compared with placebo.


Inclusion criteria

  • Rheumatoid Arthritis